These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Resistance to nucleoside reverse transcriptase inhibitors]. Leal M; Santamaría JM Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):26-9. PubMed ID: 11428055 [No Abstract] [Full Text] [Related]
6. [GESIDA Consensus document on the use of resistance studies in clinical practice]. Gatell JM; Blanco JL; Alcamí J; Antela A; Arrizabalaga J; Casado JL; Clotet B; Delgado R; Erice A; Guerra L; Guerrero A; Iribarren JA; Leal M; López JC; Menéndez-Arias L; Miró JM; Moreno S; Pérez JL; Pumarola T; Rubio R; Ruiz L; Santamaría JM; Soriano V; Telenti A; Viciana P Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):53-60. PubMed ID: 11428062 [No Abstract] [Full Text] [Related]
7. [HIV susceptibility determination: a qualified position against regarding a complex technology]. Telenti A Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):45-6. PubMed ID: 11428060 [No Abstract] [Full Text] [Related]
8. [Biological basis for generating resistance to antiretroviral drugs]. Alcamí J; Delgado R; Menéndez-Arias L Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):3-13. PubMed ID: 11428056 [No Abstract] [Full Text] [Related]
9. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement? Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R; Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650 [TBL] [Abstract][Full Text] [Related]
10. Update of the drug resistance mutations in HIV-1: 2004. Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709 [No Abstract] [Full Text] [Related]
11. [Incorporation of the test of resistance to antiretroviral drugs in clinical practice]. Soriano V; Briones C Med Clin (Barc); 1999 Mar; 112(11):412-5. PubMed ID: 10231774 [No Abstract] [Full Text] [Related]
14. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463 [TBL] [Abstract][Full Text] [Related]
15. [Tests to detect resistance to antiretroviral agents in clinical practice]. Seriano Vázquez V; Rodríguez-Rosado y Martínez-Echevarría R; Martínez-Echevarría Rev Clin Esp; 1999 Mar; 199(3):179-83. PubMed ID: 10230303 [No Abstract] [Full Text] [Related]
16. HIV drug resistance testing: an update for the clinician. Rice HL; Zolopa AR AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921 [No Abstract] [Full Text] [Related]
17. Drug resistance. An updated, user-friendly guide to genotype interpretation. MacArthur RD AIDS Read; 2000 Nov; 10(11):652-7. PubMed ID: 11186189 [TBL] [Abstract][Full Text] [Related]
18. Invirase resistance/cross-resistance data released. AIDS Patient Care STDS; 1996 Jun; 10(3):185. PubMed ID: 11361626 [No Abstract] [Full Text] [Related]
19. Viro diversity (or, keeping up with HIV's evolutionary caprice). Mascolini M IAPAC Mon; 2001 Jul; 7(7):198-207. PubMed ID: 11785465 [No Abstract] [Full Text] [Related]
20. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians. Mascolini M; Wensing AM; Boucher CA IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306 [No Abstract] [Full Text] [Related] [Next] [New Search]